Life (Jun 2023)

Age and Gender Trends in the Prevalence of Markers for Hepatitis E Virus Exposure in the Heterogeneous Bulgarian Population

  • Elitsa Golkocheva-Markova,
  • Chiydem Ismailova,
  • Ani Kevorkyan,
  • Ralitsa Raycheva,
  • Sashka Zhelyazkova,
  • Stanislav Kotsev,
  • Maria Pishmisheva,
  • Vanya Rangelova,
  • Asya Stoyanova,
  • Viliana Yoncheva,
  • Tencho Tenev,
  • Teodora Gladnishka,
  • Iva Trifonova,
  • Iva Christova,
  • Roumen Dimitrov,
  • Roberto Bruni,
  • Anna Rita Ciccaglione

DOI
https://doi.org/10.3390/life13061345
Journal volume & issue
Vol. 13, no. 6
p. 1345

Abstract

Read online

The prevalence of hepatitis E virus (HEV) in the Bulgarian population remains underestimated. The aim of the present study was to evaluate age and gender trends in HEV prevalence in the heterogeneous Bulgarian population. Stored serum samples from blood donors and different patient sub-populations—kidney recipients (KR), patients with Guillain–Barre syndrome (GBS), Lyme disease (LD), patients with liver involvement and a clinical diagnosis other than viral hepatitis A and E (non-AE), hemodialysis (HD) and HIV-positive patients (HIV)—were retrospectively investigated for markers of past and recent/ongoing HEV infection. The estimated overall seroprevalence of past infection was 10.6%, ranging from 5.9% to 24.5% for the sub-populations evaluated, while the seroprevalence of recent/ongoing HEV infection was 7.5%, ranging from 2.1% to 20.4%. The analysis of the individual sub-populations showed a different prevalence with respect to sex. In regard to age, the cohort effect was preserved, as a multimodal pattern was observed only for the GBS sub-population. Molecular analysis revealed HEV 3f and 3e. The type of the population is one of the main factors on which the anti-HEV prevalence depends, highlighting the need for the development of guidelines related to the detection and diagnosis of HEV infection with regard to specific patient populations.

Keywords